FDA VRBPAC Recommends Pfizer’s RSV Vaccine Despite Premature Birth Signals

Ten advisors voted yes, and four advisors voted no.

Chair of the Committee Dr. El-Sahly voted no and advocated for research into “vaccines that don’t interfere with other antigens, and, potentially, should this signal [premature births] be true, safer vaccines.”

Dr. Paul Offit also voted no. “I do think a lot’s at stake,” he expressed. “If you’re in any sense risking premature births with this vaccine, I think there will be a big price to pay.”

Hear why other panel members voted yes or not from the entire meeting liveblogged by Meryl Nass, M.D. on #CHDTV:

https://live.childrenshealthdefense.org/chd-tv/events/fda-vrbpac-meetings/FDA-VRBPAC-May18-liveblog/